AEON Biopharma, Inc. - 10-Q Filing
AEON Biopharma reports Q3 2026 financial results featuring complex fair value measurements for warrant liabilities and contingent considerations.
Tickers: $AEON
AEON Biopharma reports Q3 2026 financial results featuring complex fair value measurements for warrant liabilities and contingent considerations.
Tickers: $AEON